Maximus vs LTTL: Low-Cost Compounded Semaglutide Options Compared
Quick verdict: Maximus vs LTTL
Maximus is a straightforward, lower-cost telemedicine option with a $132.99 per month direct-pay model and prescriptions filled by U.S. pharmacies. LTTL emphasizes lab verification, state-licensed compounding, and promotional first-month savings but lists less-verifiable pricing details. If price and a simple online process matter most, Maximus is clearer; if independent lab testing and promotional first-month credits are priorities, LTTL may appeal.
Start Maximus pricing and telemedicine
How these providers differ at a glance
This comparison focuses on three distinctive differences supported by the sources: pricing and billing model, pharmacy and quality verification, and eligibility plus program transparency. Both offer compounded GLP-1 medications and both include the regulatory note that compounded medications are not FDA-approved.
| Criteria | Maximus | LTTL |
|---|---|---|
| Starting price | Start with $132.99 Per Month | Up to $140 off your first month; prices shown include $249 and $129 examples |
| Billing model | Direct-pay; no insurance billing | Live offer pricing and eligibility subject to change; promo code auto-applied |
| Pharmacy sourcing | Compounded in U.S. pharmacies; prescriptions filled through trusted U.S. pharmacies | Compounded by U.S.A. licensed pharmacies; prepared in state-licensed pharmacies |
| Quality verification | Uses trusted U.S. pharmacies; regulatory note on compounded status | Independently verified in FDA registered labs; confirmed every 3 to 6 months for strength |
| Availability and eligibility | Available in all 50 states except Mississippi; no in-person visits | Treatment only when a licensed clinician determines it is medically appropriate; state coverage not fully published |
Pricing and billing model compared
Maximus lists a clear flat monthly rate starting at $132.99 per month and operates as a direct-pay service that does not bill insurance. The Maximus source repeatedly highlights that price and the low flat rate as a core feature. LTTL shows promotional language such as up to $140 off the first month with a code auto-applied and price points referenced like $249 and $129, but the capture notes that current details were not published or could not be fully verified on the landing page. The difference: Maximus provides a specific starting price and a stated direct-pay model; LTTL emphasizes promotional first-month savings with less consistent published pricing details.
Compare Maximus pricing and enrollment
Pharmacy sourcing and quality verification
Both providers use U.S. compounding pharmacies and both include the regulatory note that compounded medications are not FDA-approved. Maximus emphasizes prescriptions approved by licensed doctors and filled through trusted U.S. pharmacies. LTTL states that medications are prepared in state-licensed pharmacies and are independently verified in FDA registered labs with confirmation every 3 to 6 months to stay within plus or minus 10 percent of target strength. This makes LTTL’s source emphasize independent lab verification as a distinguishing point while Maximus emphasizes trusted domestic pharmacy sourcing and licensed clinician prescriptions.
Eligibility, availability, and program transparency
Maximus states its Weight Loss Protocol is available in all 50 states except Mississippi, offers telemedicine without in-person visits, and will refund medication costs if a patient is not approved. LTTL’s source repeatedly notes that pricing, eligibility, pharmacy, state coverage and renewal terms may change and that treatment is available only when a licensed clinician determines it is medically appropriate. LTTL’s capture also notes that current details were not fully published or verified on the landing page, so the provider recommends confirming eligibility, total cost, renewal terms and state availability before enrollment.
Check LTTL eligibility and offers
What each provider highlights as strengths
Maximus highlights a low flat rate, telemedicine convenience, prescriptions approved by licensed doctors, and shipments from U.S. pharmacies. The Maximus source explicitly frames this as a simple low-cost direct-pay option. LTTL highlights independent lab verification of compounded doses, state-licensed compounding, and a promotional first-month credit with a code auto-applied. LTTL also emphasizes full-dose GLP-1 and confirmed strength testing every 3 to 6 months.
Regulatory reminder
Both providers include the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. That note appears in the source material for both Maximus and LTTL and should factor into decision making.
Conclusion: Choose based on your priorities
Maximus vs LTTL splits on clarity of price and emphasis on lab verification. Choose Maximus if you want a clearly stated lower flat rate, a direct-pay telemedicine path with prescriptions approved by licensed doctors and compounded through trusted U.S. pharmacies. Choose LTTL if independent lab verification and state-licensed compounding with promotional first-month credits are more important and you will confirm eligibility, pricing and state coverage before enrolling.